CORBUS PHARMACEUTICALS HOLDI (CRBP)

US21833P3010 - Common Stock

34.25  +0.75 (+2.24%)

After market: 34.25 0 (0%)

News Image
4 days ago - Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting

NORWOOD, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that...

News Image
9 days ago - InvestorPlace

These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

News Image
16 days ago - InvestorPlace

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.

News Image
26 days ago - InvestorPlace

5 Healthcare Stocks to Buy for 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

News Image
a month ago - Corbus Pharmaceuticals Holdings, Inc.

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC

Study enrolling patients with metastatic urothelial cancer (mUC) and other Nectin-4 enriched tumorsEmerging clinical profile from CSPC’s Phase 1 China...

News Image
2 months ago - Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Encouraging CRB-701 (SYS6002) First-in-Human Data Presented at ASCO-GU 2024; first patient expected to be dosed in US Ph1 study by end of March 2024 ...

News Image
2 months ago - Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit

NORWOOD, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that...

News Image
2 months ago - Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer

NORWOOD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology...

News Image
3 months ago - InvestorPlace

The 3 Most Undervalued Biotech Stocks to Buy in February 2024

With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.

News Image
3 months ago - BusinessInsider

The 3 Most Undervalued Biotech Stocks to Buy in February 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With patience, some of the most undervalued biotech stocks can create massive w...